IMS Health Holdings (IMS), an information and technology provider for the health-care and life-sciences industries, on Tuesday reported Q4 earnings above the Street view despite lower-than-expected revenue, while it forecast higher revenue and earnings for 2015.
The company reported Q4 net income of $8 million, or $0.03 per diluted share, down from $82 million, or $0.29 per share, a year earlier. The per-share comparison was skewed by a 21% jump in the number of shares outstanding.
On an adjusted basis, the company posted EPS of $0.36, up from $0.28 in the same period a year earlier and topping the Street view according to Capital IQ for $0.34.
Total revenue of $678 million was up from $674 million in Q4 2013 but missed analysts’ mean projection of $679.3 million.
Revenue performance in Q4 was driven by a 14% increase in technology-services revenue on a constant-currency basis, or a rise of 8.8% on a reported basis, the company said.
For 2015, the company forecast reported revenue growth of 11% to 12%, and adjusted EPS growth of 4% to 6%. Analysts recently were projecting 2015 revenue of $2.80 billion, up 6.1% from 2014. The Street’s consensus estimate was for 2015 adjusted EPS of $1.50, up 9.5% from 2014.
Shares of IMS were inactive pre-market after closing Monday at $24.99, within a 52-week range of $21.63 to $28.48.